#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Acute hepatic failure Central nervous system lymphoma Metabolic disorder Chondrosarcoma Dupuytren's contracture Hypotransferrinaemia Rectal cancer Antisynthetase syndrome Small intestine adenocarcinoma Thalassaemia alpha Autoimmune haemolytic anaemia Small for dates baby Uveal melanoma Thrombocytopenia Paraneoplastic neurological syndrome More trials…

    Learn about Rare Diseases

    Myelodysplastic syndrome – Life with Disease Synovial sarcoma recurrent – Treatment Acute respiratory distress syndrome – Diagnostics Synovial sarcoma recurrent – Diagnostics Netherton’s syndrome Pleomorphic leiomyosarcoma – Life with Disease Sarcoma – Diagnostics Angiosarcoma metastatic – Trials in Disease Synovial sarcoma recurrent – Life with Disease Angiosarcoma metastatic – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Baloxavir Marboxil Cart45Ra-Nkg2D Cells Ixazomib ASP2957 Milademetan Alx148 Treosulfan Tofacitinib Afatinib [18F]Fluoro-Peg-Folate XENON (133XE) AB521 Tamsulosin Hydrochloride Copper (64Cu) Chloride Rezvilutamide Paxalisib Imipramine Hydrochloride Amniotic Membrane, Human Adrenaline Tartrate Ph. Eur. Ds-3939A More therapies…

    Learn about Your Condition

    Chronic kidney disease Pleomorphic leiomyosarcoma Insulin resistance Open angle glaucoma Arthroscopy Essential hypertension Mantle cell lymphoma stage II Rectal adenocarcinoma Krabbe's disease Ovarian granulosa cell tumour Pulmonary venous thrombosis Diabetes insipidus Breast cancer stage III Embolic stroke Fungal infection More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Hip fracture

  • Study on the Effects of Ferric Derisomaltose on Mobility in Elderly Patients After Hip Fracture Surgery

    Recruiting

    3 1 1
    Investigated Diseases:
    • Hip fracture
    Investigated Drugs:
    • Ferric Derisomaltose
    • Sodium Chloride
    Denmark

  • Efficacy of Tranexamic Acid in Reducing Perioperative Blood Loss in Patients with Hip Fracture: A Randomized, Double-Blind Clinical Trial

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Hip fracture
    Investigated Drugs:
    • Tranexamic Acid
    Spain

  • Study on the Safety of Levobupivacaine and Bupivacaine with Fentanyl for Anesthesia in Patients Over 65 Undergoing Hip Fracture Surgery

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Hip fracture
    Investigated Drugs:
    • Bupivacaine Hydrochloride
    • Levobupivacaine
    • Epinephrine
    Spain

  • Study on Pain Relief in Hip Fracture Surgery: Comparing Levobupivacaine Block with No Block for Patients Undergoing Hip and Proximal Femur Surgery

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Hip fracture
    Investigated Drugs:
    • Levobupivacaine
    Spain

  • Study on Zoledronic Acid for Patients with Hip Fractures: Evaluating Early Treatment Safety and Effectiveness

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Hip fracture
    Investigated Drugs:
    • Zoledronic Acid
    Norway

  • Study on Preventing Constipation After Hip Fracture Surgery Using Bisacodyl and a Drug Combination for Post-Surgery Patients

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Bisacodyl
    • Macrogol 4000
    • Simeticone
    Denmark

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!